RWP
CELG

RWA Wealth Partners’s Celgene Corp CELG Stock Holding History

RWA Wealth Partners’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-622
Closed -$49K – 819
2018
Q2 		$49K Buy
622
+565
+991% +$46.9K 0.01% 418
2018
Q1 		$5K Buy
+57
New +$5.47K ﹤0.01% 499

Other funds holding CELG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Edgewood Management
Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

RWA Wealth Partners's CELG Position: Q3 2018 in Review

RWA Wealth Partners sold out of Celgene Corp (CELG) in Q3 2018, closing a stake of 622 shares — an estimated $49K sold.

RWA Wealth Partners first reported a position in CELG in Q1 2018 and held it in 2 quarters. The position peaked at $49K in Q2 2018. 1,364 funds tracked by Wall St. Rank hold CELG as of Q3 2018.

  • RWA Wealth Partners reported no remaining Celgene Corp position as of Q3 2018 after selling out during the quarter.
  • RWA Wealth Partners sold 622 Celgene Corp shares in Q3 2018, an estimated $49K.
  • RWA Wealth Partners first reported a position in Celgene Corp in Q1 2018 and held it in 2 quarters.
  • RWA Wealth Partners's Celgene Corp position peaked at $49K in Q2 2018.
  • 1,364 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2018.

Based on RWA Wealth Partners's 13F filing for Q3 2018, filed 14 Nov 2018.